6,418.00
0.00
(0.00%)
At close: January 30 at 11:14:58 AM CST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
16,095,000.00
16,095,000.00
17,803,000.00
20,976,000.00
18,566,000.00
Investing Cash Flow
-10,643,000.00
-10,643,000.00
-2,924,000.00
-6,552,000.00
-9,067,000.00
Financing Cash Flow
-4,239,000.00
-4,239,000.00
-16,275,000.00
-13,108,000.00
-9,666,000.00
End Cash Position
5,376,000.00
5,376,000.00
4,991,000.00
6,850,000.00
5,727,000.00
Capital Expenditure
-4,649,000.00
-4,649,000.00
-4,552,000.00
-4,549,000.00
-6,690,000.00
Issuance of Capital Stock
-1,144,000.00
-1,144,000.00
-1,257,000.00
-1,406,000.00
-2,126,000.00
Issuance of Debt
8,342,000.00
8,342,000.00
8,442,000.00
20,312,000.00
341,000.00
Repayment of Debt
-1,751,000.00
-1,751,000.00
-15,433,000.00
-2,448,000.00
--
Repurchase of Capital Stock
--
--
--
-18,991,000.00
--
Free Cash Flow
11,446,000.00
11,446,000.00
13,251,000.00
16,427,000.00
11,876,000.00
12/31/2020 - 12/9/2013
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ZEGA.F AstraZeneca PLC
67.50
+0.75%
NVSEF Novartis AG
101.26
0.00%
BAYRY Bayer Aktiengesellschaft
5.64
-1.05%
NVS Novartis AG
104.72
-0.03%
OGN Organon & Co.
15.56
-2.57%
GSK GSK plc
35.27
-0.25%
AZN AstraZeneca PLC
70.76
-0.67%
AMGN Amgen Inc.
285.42
+0.49%
GILD Gilead Sciences, Inc.
97.20
+0.26%
ABBV AbbVie Inc.
183.90
+4.70%